TLL-28807-10385
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 201 / VA
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- 337-30162-35182
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — Moderna
-
2022-06-27
Registered in v-safe
- 2022-06-27
-
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-07-03
- 2022-07-15
- 2022-07-24
-
2022-07-30
Dose 2 — Moderna
- 2022-08-03
- 2022-08-04
- 2022-08-05
- 2022-08-06
-
2022-08-19
Survey response — day 14, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | No |
| 2 | 2022-07-30 | Moderna | No |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Cough, runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release